Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2026 | A portable MRI device: improving access to care with applications in MS and stroke

Anthony Traboulsee • 28 Jun 2026
EAN 2026
Multiple Sclerosis and Related Disorders Stroke

Anthony Traboulsee, MD, University of British Columbia, Vancouver, Canada, comments on the potential of a portable MRI device to revolutionize care in areas with limited access to traditional MRI machines. Prof. Traboulsee highlights that this low-field MRI technology can produce good-quality images of the brain, including small strokes and multiple sclerosis (MS) lesions. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Anthony Traboulsee

Recent approval of tolebrutinib in the EU for secondary progressive MS without relapses
0:37
Recent approval of tolebrutinib in the EU for secondary progressive MS without relapses
Anthony Traboulsee • 28 Jun 2026
Tolebrutinib and disability by MRI activity: post-hoc analysis of HERCULES and GEMINI
1:07
Tolebrutinib and disability by MRI activity: post-hoc analysis of HERCULES and GEMINI
Anthony Traboulsee • 28 Jun 2026
Tolebrutinib reduces new MRI lesions in highly active relapsing MS
2:28
Tolebrutinib reduces new MRI lesions in highly active relapsing MS
Anthony Traboulsee • 9 Apr 2021
Phase III trials of tolebrutinib in relapsing-remitting and progressive MS
2:20
Phase III trials of tolebrutinib in relapsing-remitting and progressive MS
Anthony Traboulsee • 9 Apr 2021

Related Videos

Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features
2:52
Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features
Alicja Kalinowska • 28 Jun 2026
A debate at EAN 2026: does prodromal MS exist?
2:23
A debate at EAN 2026: does prodromal MS exist?
Alicja Kalinowska • 28 Jun 2026
Approaches to improving the quality of life of patients with MS during the menopause
1:13
Approaches to improving the quality of life of patients with MS during the menopause
Celia Oreja-Guevara • 29 Jun 2026
NfL and GFAP for individualised treatment in MS: two independent large observational cohorts
2:13
NfL and GFAP for individualised treatment in MS: two independent large observational cohorts
Maximilian Einsiedler • 28 Jun 2026
The content of VJNeurology is intended for healthcare professionals